Historical source coverage

2017

230 selected records with a cited source date in 2017, shown 200 per page, newest first. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2017 by record type

3 types

December 2017

11 records on this page

Clinical trials · Terlipressin

ClinicalTrials.gov record NCT02588716

PeptideScanner retained ClinicalTrials.gov record NCT02588716 at 2026-11-15T21:47:40.408Z. Its registry update date was 2017-12-27, and PeptideScanner's reviewed identity mapping was terlipressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 27894941

PeptideScanner retained PubMed bibliographic metadata for PMID 27894941 at 2026-07-30T21:22:58.009Z. PubMed recorded a metadata revision date of 2017-12-23 and an Entrez history date of 2016-11-30. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Glepaglutide

ClinicalTrials.gov record NCT03279302

PeptideScanner retained ClinicalTrials.gov record NCT03279302 at 2026-11-16T01:46:56.290Z. Its registry update date was 2017-12-22, and PeptideScanner's reviewed identity mapping was glepaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Terlipressin

ClinicalTrials.gov record NCT02718599

PeptideScanner retained ClinicalTrials.gov record NCT02718599 at 2026-11-15T21:47:40.408Z. Its registry update date was 2017-12-19, and PeptideScanner's reviewed identity mapping was terlipressin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01705587

PeptideScanner retained ClinicalTrials.gov record NCT01705587 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-12-12, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Bivalirudin

ClinicalTrials.gov record NCT00433966

PeptideScanner retained ClinicalTrials.gov record NCT00433966 at 2026-11-15T21:58:19.888Z. Its registry update date was 2017-12-04, and PeptideScanner's reviewed identity mapping was bivalirudin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT02079870

PeptideScanner retained ClinicalTrials.gov record NCT02079870 at 2026-07-30T21:22:00.245Z. Its registry update date was 2017-12-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Octreotide

Federal Register notice 2017-25920

The Federal Register published notice 2017-25920, attributed to FDA and its parent HHS department, on 2017-12-01. Its official title is “Barr Laboratories, Inc. et al.; Withdrawal of Approval of 68 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Octreotide.

Source: Federal Register via GovInfo ↗

→

November 2017

63 records on this page

Clinical trials · Lixisenatide

ClinicalTrials.gov record NCT02745470

PeptideScanner retained ClinicalTrials.gov record NCT02745470 at 2026-07-30T21:22:00.254Z. Its registry update date was 2017-11-29, and PeptideScanner's reviewed identity mapping was lixisenatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Metreleptin

ClinicalTrials.gov record NCT00596934

PeptideScanner retained ClinicalTrials.gov record NCT00596934 at 2026-11-16T17:35:38.955Z. Its registry update date was 2017-11-24, and PeptideScanner's reviewed identity mapping was metreleptin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT01762943

PeptideScanner retained ClinicalTrials.gov record NCT01762943 at 2026-07-30T21:22:00.263Z. Its registry update date was 2017-11-20, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT02102204

PeptideScanner retained ClinicalTrials.gov record NCT02102204 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-11-17, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Metreleptin

USAN Council. List No.431. New names. Metreleptin.

PubMed lists PMID 11184472 in Clinical pharmacology and therapeutics as Journal Article, with publication-date metadata of 2000-10 (month precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-6

Structure-activity analysis of the growth hormone secretagogue GHRP-6 by alpha- and beta-amino gamma-lactam positional scanning.

PubMed lists PMID 19954433 in Chemical biology & drug design as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2010-01 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Peginesatide

Methods for detection and confirmation of Hematide™/peginesatide in anti-doping samples.

PubMed lists PMID 21816551 in Forensic science international as Journal Article, with publication-date metadata of 2011-08-03 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Peginesatide

Peginesatide as a new approach for treating anemia of CKD patient: is it like a falling star?

PubMed lists PMID 23675762 in Expert opinion on pharmacotherapy as Editorial, with publication-date metadata of 2013-05-16 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Metreleptin

Metreleptin (Myalept): a leptin analog for generalized lipodystrophy.

PubMed lists PMID 25581107 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2015-01-19 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Peginesatide

Watch out for a revival of peginesatide in sports.

PubMed lists PMID 27279382 in Drug testing and analysis as Journal Article, with publication-date metadata of 2016-06-09 (day precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymopentin

Immunomodulation with thymopentin in humans.

PubMed lists PMID 6398312 in International journal of clinical pharmacology research as Clinical Trial, Controlled Clinical Trial, Journal Article, with publication-date metadata of 1984 (year precision). PeptideScanner associated the retained record with the identity slug thymopentin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

[The use of Synarel (nafarelin acetate--spray) in gynecology].

PubMed lists PMID 7485786 in Akusherstvo i ginekologiia as Journal Article, with publication-date metadata of 1994 (year precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Icatibant

Icatibant for the treatment of hereditary angioedema.

PubMed lists PMID 23249729 in The Annals of pharmacotherapy as Comparative Study, Journal Article, Review, with publication-date metadata of 2012-12-18 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Linaclotide

Constella™(EU)-Linzess™(USA): the last milestone in the long journey of the peptide linaclotide and its implications for the future of peptide drugs.

PubMed lists PMID 23464519 in Future medicinal chemistry as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2013-03 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Linaclotide

Linaclotide for constipation-predominant IBS.

PubMed lists PMID 24227771 in Drug and therapeutics bulletin as Journal Article, with publication-date metadata of 2013-11 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · BPC-157

Pentadecapeptide BPC 157 and anaphylactoid reaction in rats and mice after intravenous dextran and white egg administration.

PubMed lists PMID 24486708 in European journal of pharmacology as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2014-01-31 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Linaclotide

Economic evaluation of linaclotide for the treatment of adult patients with irritable bowel syndrome with constipation in the United States.

PubMed lists PMID 25333331 in Journal of medical economics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04 (month precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · BPC-157

Perforating corneal injury in rat and pentadecapeptide BPC 157.

PubMed lists PMID 25912999 in Experimental eye research as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-04-24 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · BPC-157

BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias.

PubMed lists PMID 27060013 in European journal of pharmacology as Journal Article, with publication-date metadata of 2016-04-06 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · BPC-157

Stable gastric pentadecapeptide BPC 157 and bupivacaine.

PubMed lists PMID 27815173 in European journal of pharmacology as Journal Article, with publication-date metadata of 2016-11-01 (day precision). PeptideScanner associated the retained record with the identity slug bpc-157. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Epitalon

PubMed record PMID 12101568

PeptideScanner retained PubMed bibliographic metadata for PMID 12101568 at 2026-07-30T21:22:56.967Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2002-07-10. PeptideScanner associated this retained record with the identity slug epitalon. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 15381050

PeptideScanner retained PubMed bibliographic metadata for PMID 15381050 at 2026-07-30T21:22:56.969Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2004-09-24. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 15774286

PeptideScanner retained PubMed bibliographic metadata for PMID 15774286 at 2026-07-30T21:22:56.970Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-03-19. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 15840402

PeptideScanner retained PubMed bibliographic metadata for PMID 15840402 at 2026-07-30T21:22:56.970Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-04-21. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 16117343

PeptideScanner retained PubMed bibliographic metadata for PMID 16117343 at 2026-07-30T21:22:56.971Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-08-25. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 16369461

PeptideScanner retained PubMed bibliographic metadata for PMID 16369461 at 2026-07-30T21:22:56.972Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2005-12-22. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 16583442

PeptideScanner retained PubMed bibliographic metadata for PMID 16583442 at 2026-07-30T21:22:56.973Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2006-04-04. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 16609979

PeptideScanner retained PubMed bibliographic metadata for PMID 16609979 at 2026-07-30T21:22:56.973Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2006-04-13. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Linaclotide

PubMed record PMID 17694454

PeptideScanner retained PubMed bibliographic metadata for PMID 17694454 at 2026-07-30T21:22:56.977Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2007-08-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 18594781

PeptideScanner retained PubMed bibliographic metadata for PMID 18594781 at 2026-07-30T21:22:56.978Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-07-03. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Linaclotide

PubMed record PMID 19098860

PeptideScanner retained PubMed bibliographic metadata for PMID 19098860 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-12-23. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 19465062

PeptideScanner retained PubMed bibliographic metadata for PMID 19465062 at 2026-07-30T21:22:56.982Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-05-26. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Linaclotide

PubMed record PMID 19706070

PeptideScanner retained PubMed bibliographic metadata for PMID 19706070 at 2026-07-30T21:22:57.963Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-08-27. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 19903499

PeptideScanner retained PubMed bibliographic metadata for PMID 19903499 at 2026-07-30T21:22:57.965Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-11-12. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 19931318

PeptideScanner retained PubMed bibliographic metadata for PMID 19931318 at 2026-07-30T21:22:57.965Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2009-11-26. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 20190676

PeptideScanner retained PubMed bibliographic metadata for PMID 20190676 at 2026-07-30T21:22:57.967Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-03-02. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Linaclotide

PubMed record PMID 20560145

PeptideScanner retained PubMed bibliographic metadata for PMID 20560145 at 2026-07-30T21:22:57.971Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-06-19. PeptideScanner associated this retained record with the identity slug linaclotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Tesamorelin

PubMed record PMID 22050344

PeptideScanner retained PubMed bibliographic metadata for PMID 22050344 at 2026-07-30T21:22:57.978Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2011-11-05. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 25402764

PeptideScanner retained PubMed bibliographic metadata for PMID 25402764 at 2026-07-30T21:22:57.992Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2014-11-18. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 26979527

PeptideScanner retained PubMed bibliographic metadata for PMID 26979527 at 2026-07-30T21:22:57.999Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2016-03-17. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 11742568

PeptideScanner retained PubMed bibliographic metadata for PMID 11742568 at 2026-07-30T21:22:56.965Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2001-12-18. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 11978191

PeptideScanner retained PubMed bibliographic metadata for PMID 11978191 at 2026-07-30T21:22:56.966Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2002-04-30. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · BPC-157

PubMed record PMID 14554208

PeptideScanner retained PubMed bibliographic metadata for PMID 14554208 at 2026-07-30T21:22:56.968Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2003-10-14. PeptideScanner associated this retained record with the identity slug bpc-157. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Tesamorelin

PubMed record PMID 17575575

PeptideScanner retained PubMed bibliographic metadata for PMID 17575575 at 2026-07-30T21:22:56.977Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2007-06-19. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Tesamorelin

PubMed record PMID 18690162

PeptideScanner retained PubMed bibliographic metadata for PMID 18690162 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-08-12. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Tesamorelin

PubMed record PMID 18724445

PeptideScanner retained PubMed bibliographic metadata for PMID 18724445 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-08-30. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Tesamorelin

PubMed record PMID 18828236

PeptideScanner retained PubMed bibliographic metadata for PMID 18828236 at 2026-07-30T21:22:56.979Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2008-10-03. PeptideScanner associated this retained record with the identity slug tesamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 23407924

PeptideScanner retained PubMed bibliographic metadata for PMID 23407924 at 2026-07-30T21:22:57.984Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2013-02-15. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 23884489

PeptideScanner retained PubMed bibliographic metadata for PMID 23884489 at 2026-07-30T21:22:57.985Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2013-07-26. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 25230094

PeptideScanner retained PubMed bibliographic metadata for PMID 25230094 at 2026-07-30T21:22:57.990Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2014-09-18. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 25470471

PeptideScanner retained PubMed bibliographic metadata for PMID 25470471 at 2026-07-30T21:22:57.992Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2014-12-04. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 21073357

PeptideScanner retained PubMed bibliographic metadata for PMID 21073357 at 2026-07-30T21:22:57.974Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2010-11-16. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 21597671

PeptideScanner retained PubMed bibliographic metadata for PMID 21597671 at 2026-07-30T21:22:57.976Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2011-05-21. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Afamelanotide

PubMed record PMID 23277150

PeptideScanner retained PubMed bibliographic metadata for PMID 23277150 at 2026-07-30T21:22:57.983Z. PubMed recorded a metadata revision date of 2017-11-16 and an Entrez history date of 2013-01-02. PeptideScanner associated this retained record with the identity slug afamelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Octreotide

ClinicalTrials.gov record NCT03061604

PeptideScanner retained ClinicalTrials.gov record NCT03061604 at 2026-07-30T21:22:00.250Z. Its registry update date was 2017-11-14, and PeptideScanner's reviewed identity mapping was octreotide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Degarelix

A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy.

PubMed lists PMID 27756786 in Clinical cancer research : an official journal of the American Association for Cancer Research as Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2016-10-18 (day precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT00422058

PeptideScanner retained ClinicalTrials.gov record NCT00422058 at 2026-07-30T21:22:00.247Z. Its registry update date was 2017-11-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT00781937

PeptideScanner retained ClinicalTrials.gov record NCT00781937 at 2026-07-30T21:22:00.250Z. Its registry update date was 2017-11-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01557166

PeptideScanner retained ClinicalTrials.gov record NCT01557166 at 2026-07-30T21:22:00.252Z. Its registry update date was 2017-11-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

October 2017

19 records on this page

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT01263717

PeptideScanner retained ClinicalTrials.gov record NCT01263717 at 2026-07-30T21:22:00.255Z. Its registry update date was 2017-10-30, and PeptideScanner's reviewed identity mapping was tesamorelin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Terlipressin

ClinicalTrials.gov record NCT00089570

PeptideScanner retained ClinicalTrials.gov record NCT00089570 at 2026-11-15T21:47:40.408Z. Its registry update date was 2017-10-27, and PeptideScanner's reviewed identity mapping was terlipressin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02647944

PeptideScanner retained ClinicalTrials.gov record NCT02647944 at 2026-07-30T21:22:00.265Z. Its registry update date was 2017-10-27, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Bremelanotide

PubMed record PMID 16839319

PeptideScanner retained PubMed bibliographic metadata for PMID 16839319 at 2026-07-30T21:22:56.974Z. PubMed recorded a metadata revision date of 2017-10-16 and an Entrez history date of 2006-07-15. PeptideScanner associated this retained record with the identity slug bremelanotide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT00223717

PeptideScanner retained ClinicalTrials.gov record NCT00223717 at 2026-11-16T01:33:21.554Z. Its registry update date was 2017-10-13, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

Regulatory · Glatiramer acetate

Drugs@FDA application ANDA091646

The official Drugs@FDA dataset lists original submission 1 for ANDA 091646 with status AP dated 2017-10-03, and names glatiramer acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Regulatory · Glatiramer acetate

Drugs@FDA application ANDA206936

The official Drugs@FDA dataset lists original submission 1 for ANDA 206936 with status AP dated 2017-10-03, and names glatiramer acetate among the application record's active ingredients.

Source: Drugs@FDA via openFDA ↗

→

Regulatory · Semaglutide

Federal Register notice 2017-21176

The Federal Register published notice 2017-21176, attributed to FDA and its parent HHS department, on 2017-10-03. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Semaglutide.

Source: Federal Register via GovInfo ↗

→

Regulatory · Glucagon + 2 more

Federal Register notice 2017-21202

The Federal Register published notice 2017-21202, attributed to FDA and its parent HHS department, on 2017-10-03. Its official title is “Abbreviated New Drug Applications for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of Recombinant Deoxyribonucleic Acid Origin; Draft Guidance for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Glucagon, Liraglutide and Teriparatide.

Source: Federal Register via GovInfo ↗

→

September 2017

14 records on this page

Literature metadata · Kisspeptin-10

Kisspeptin-10 and the G protein-coupled receptor 54 are differentially expressed in the canine pregnant uterus and trophoblast cells.

PubMed lists PMID 27774662 in Reproduction in domestic animals = Zuchthygiene as Journal Article, with publication-date metadata of 2016-10-23 (day precision). PeptideScanner associated the retained record with the identity slug kisspeptin-10. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Larazotide

ClinicalTrials.gov record NCT00492960

PeptideScanner retained ClinicalTrials.gov record NCT00492960 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Larazotide

ClinicalTrials.gov record NCT00620451

PeptideScanner retained ClinicalTrials.gov record NCT00620451 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Larazotide

ClinicalTrials.gov record NCT00889473

PeptideScanner retained ClinicalTrials.gov record NCT00889473 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Larazotide

ClinicalTrials.gov record NCT01396213

PeptideScanner retained ClinicalTrials.gov record NCT01396213 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-20, and PeptideScanner's reviewed identity mapping was larazotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Larazotide

ClinicalTrials.gov record NCT00362856

PeptideScanner retained ClinicalTrials.gov record NCT00362856 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-12, and PeptideScanner's reviewed identity mapping was larazotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Larazotide

ClinicalTrials.gov record NCT00386490

PeptideScanner retained ClinicalTrials.gov record NCT00386490 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-12, and PeptideScanner's reviewed identity mapping was larazotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Larazotide

ClinicalTrials.gov record NCT00386165

PeptideScanner retained ClinicalTrials.gov record NCT00386165 at 2026-11-16T01:45:58.486Z. Its registry update date was 2017-09-11, and PeptideScanner's reviewed identity mapping was larazotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Daptomycin

ClinicalTrials.gov record NCT00295178

PeptideScanner retained ClinicalTrials.gov record NCT00295178 at 2026-11-15T22:01:45.056Z. Its registry update date was 2017-09-07, and PeptideScanner's reviewed identity mapping was daptomycin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT02321878

PeptideScanner retained ClinicalTrials.gov record NCT02321878 at 2026-07-30T21:23:14.758Z. Its registry update date was 2017-09-01, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

August 2017

7 records on this page

Regulatory · Desmopressin

Federal Register notice 2017-16581

The Federal Register published notice 2017-16581, attributed to FDA and its parent HHS department, on 2017-08-07. Its official title is “Product-Specific Guidances; Final Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Desmopressin.

Source: Federal Register via GovInfo ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01153425

PeptideScanner retained ClinicalTrials.gov record NCT01153425 at 2026-07-30T21:23:14.757Z. Its registry update date was 2017-08-04, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

July 2017

8 records on this page

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT01552343

PeptideScanner retained ClinicalTrials.gov record NCT01552343 at 2026-11-16T01:33:21.554Z. Its registry update date was 2017-07-11, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

June 2017

15 records on this page

Regulatory · Leuprolide + 1 more

Federal Register notice 2017-12908

The Federal Register published notice 2017-12908, attributed to FDA and its parent HHS department, on 2017-06-21. Its official title is “Wyeth Pharmaceuticals Inc. et al.; Withdrawal of Approval of 121 New Drug Applications and 161 Abbreviated New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Leuprolide and Octreotide.

Source: Federal Register via GovInfo ↗

→

May 2017

20 records on this page

Clinical trials · Calcitonin salmon

ClinicalTrials.gov record NCT01652573

PeptideScanner retained ClinicalTrials.gov record NCT01652573 at 2026-11-15T21:54:02.201Z. Its registry update date was 2017-05-31, and PeptideScanner's reviewed identity mapping was calcitonin-salmon.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Abaloparatide

PubMed record PMID 28160873

PeptideScanner retained PubMed bibliographic metadata for PMID 28160873 at 2026-07-30T21:25:18.679Z. PubMed recorded a metadata revision date of 2017-05-31 and an Entrez history date of 2017-02-06. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Ipamorelin

PubMed record PMID 12168778

PeptideScanner retained PubMed bibliographic metadata for PMID 12168778 at 2026-07-30T21:25:18.666Z. PubMed recorded a metadata revision date of 2017-05-29 and an Entrez history date of 2002-08-10. PeptideScanner associated this retained record with the identity slug ipamorelin. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Regulatory · Liraglutide

Federal Register notice 2017-10326

The Federal Register published notice 2017-10326, attributed to FDA and its parent HHS department, on 2017-05-22. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments,” and PeptideScanner's exact reviewed identity mapping connects the document to Liraglutide.

Source: Federal Register via GovInfo ↗

→

April 2017

20 records on this page

Literature metadata · Mecasermin

Mecasermin rinfabate.

PubMed lists PMID 17380212 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2007-03 (month precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Ziconotide

Ziconotide: a new option for refractory pain.

PubMed lists PMID 16845440 in Drugs of today (Barcelona, Spain : 1998) as Journal Article, Review, with publication-date metadata of 2006-06 (month precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Dasiglucagon

ClinicalTrials.gov record NCT02916251

PeptideScanner retained ClinicalTrials.gov record NCT02916251 at 2026-11-16T01:42:39.027Z. Its registry update date was 2017-04-21, and PeptideScanner's reviewed identity mapping was dasiglucagon.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT01134549

PeptideScanner retained ClinicalTrials.gov record NCT01134549 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-14, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT01254565

PeptideScanner retained ClinicalTrials.gov record NCT01254565 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-13, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Etelcalcetide

ClinicalTrials.gov record NCT01414114

PeptideScanner retained ClinicalTrials.gov record NCT01414114 at 2026-11-15T22:07:29.454Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was etelcalcetide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Teriparatide

ClinicalTrials.gov record NCT01400516

PeptideScanner retained ClinicalTrials.gov record NCT01400516 at 2026-07-30T21:24:24.225Z. Its registry update date was 2017-04-11, and PeptideScanner's reviewed identity mapping was teriparatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT01994330

PeptideScanner retained ClinicalTrials.gov record NCT01994330 at 2026-11-16T01:33:21.554Z. Its registry update date was 2017-04-05, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

March 2017

14 records on this page

Clinical trials · Glatiramer acetate

ClinicalTrials.gov record NCT00947752

PeptideScanner retained ClinicalTrials.gov record NCT00947752 at 2026-11-16T17:42:50.457Z. Its registry update date was 2017-03-14, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Icatibant

Icatibant as acute treatment for hereditary angioedema in adults.

PubMed lists PMID 27123689 in Expert review of clinical pharmacology as Journal Article, Review, with publication-date metadata of 2016-05-13 (day precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dulaglutide

PubMed record PMID 25715416

PeptideScanner retained PubMed bibliographic metadata for PMID 25715416 at 2026-07-30T21:26:46.054Z. PubMed recorded a metadata revision date of 2017-03-08 and an Entrez history date of 2015-02-26. PeptideScanner associated this retained record with the identity slug dulaglutide. These dates describe PubMed metadata history, not the article's original publication date.

Source: PubMed ↗

→

Literature metadata · Calcitonin salmon

[The influence of salmon calcitonin on the soluble form of VCAM-1 (CD 106) and E-selectin (CD 62E) in serum of patients with atopic bronchial asthma].

PubMed lists PMID 9640081 in Polskie Archiwum Medycyny Wewnetrznej as Clinical Trial, Controlled Clinical Trial, English Abstract, Journal Article, with publication-date metadata of 1997-12 (month precision). PeptideScanner associated the retained record with the identity slug calcitonin-salmon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

[Nafarelin acetate (Synarel) and thermocoagulation in the treatment of endometriosis].

PubMed lists PMID 11526758 in Ginekologia polska as Clinical Trial, English Abstract, Journal Article, with publication-date metadata of 2001-05 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

February 2017

9 records on this page

Clinical trials · Albiglutide

ClinicalTrials.gov record NCT01098539

PeptideScanner retained ClinicalTrials.gov record NCT01098539 at 2026-11-16T17:45:42.793Z. Its registry update date was 2017-02-28, and PeptideScanner's reviewed identity mapping was albiglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eptifibatide

ClinicalTrials.gov record NCT01919723

PeptideScanner retained ClinicalTrials.gov record NCT01919723 at 2026-11-15T21:59:29.646Z. Its registry update date was 2017-02-28, and PeptideScanner's reviewed identity mapping was eptifibatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01518101

PeptideScanner retained ClinicalTrials.gov record NCT01518101 at 2026-07-30T21:25:36.782Z. Its registry update date was 2017-02-27, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00171886

PeptideScanner retained ClinicalTrials.gov record NCT00171886 at 2026-07-30T21:25:36.764Z. Its registry update date was 2017-02-24, and PeptideScanner's reviewed identity mapping was octreotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT01128894

PeptideScanner retained ClinicalTrials.gov record NCT01128894 at 2026-07-30T21:25:36.852Z. Its registry update date was 2017-02-23, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Ziconotide

Perioperative Management of a Patient With an Intrathecal Drug Delivery Device Infusing Ziconotide: A Case Report.

PubMed lists PMID 28195861 in A & A case reports as Case Reports, Journal Article, with publication-date metadata of 2017-02-15 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→